Home / Learn / Immunotherapy / eLearning / Archived IO Webinar Details

Webinar: Cancer Immunotherapies: Planning for Survivorship after Checkpoint Inhibitors

Part 3 of a 3-Part Series on Cancer Immunotherapies and Care Coordination Between the Multi-Specialty Team Members

Survivorship care plans are a key piece of coordinated, patient-centered care delivery, and a requirement for Commission on Cancer accreditation. This one-hour webinar identifies challenges and solutions for immuno-oncology survivorship care planning; prepares your team for the nuances of survivorship care planning; and optimizes coordination and communication between the care team and the patient.

Featured Speakers:

Sigrun Hallmeyer, MD
Director, Cancer Institute; Medical Director, Cancer Survivorship Program, Advocate Lutheran General Hospital
Co-Director, PRC Russell Institute for Research and Innovation
Park Ridge, IL

Mary Hurd, RN, BSN, MHA
Manager, Cancer Survivorship & Bone Marrow Transplant Programs
Advocate Lutheran General Hospital, Department of Oncology
Park Ridge, IL

Jennifer Wang, LCSW
Clinical Social Worker
Advocate Lutheran General Hospital, Department of Oncology
Park Ridge, IL

Agnes Richardson
Patient Presenter

Learning Objectives: 

  • Identify challenges and solutions for immuno-oncology survivorship care planning
  • Prepare your team for nuances related to survivorship for patients on cancer immunotherapies
  • Optimize coordination and communication between the care team and the patient

This webinar is made possible by support from Bristol-Myers Squibb (charitable donation); EMD Serono; Kite, a Gilead Company; and Merck & Co, Inc (educational grant).